Skip to main content
. 2023 Aug 31;2023(8):CD006119. doi: 10.1002/14651858.CD006119.pub4

Comparison 1. Immediate versus delayed treatment in women with increased CA125 levels.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Overall survival 1 529 Hazard Ratio (IV, Random, 95% CI) 0.98 [0.80, 1.20]